Controlled Lesion and Immune Response to Pulsed Electric Field Therapy
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 12,788,463 | Controlled Lesion and Immune Response to Pulsed Electric Field Therapy In force · Medium confidence | Galvanize Therapeutics, Inc. | In force | Medium confidence | ||
| Application 18/792,495 | Controlled Lesion and Immune Response to Pulsed Electric Field Therapy Pending Not granted | Galvanize Therapeutics, Inc. | Pending | Not granted | ||
| Application 19/087,408 | Immune Response to Pulsed Electric Field Therapy Pending Not granted | Galvanize Therapeutics, Inc. | Pending | Not granted | ||
| Application 19/684,827 | Immune Response to Pulsed Electric Field Therapy Pending Not granted | Galvanize Therapeutics, Inc. | Pending | Not granted |
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Galvanize Therapeutics, Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.